Please enable JavaScript to continue using this application.

Compare $CRL vs $ILMN | Chartloom

Compare

$CRL vs $ILMN

Charles River Laboratories International Inc · Illumina Inc

CRL

Charles River Laboratories International Inc

ILMN

Illumina Inc

Compare $CRL vs $ILMN

Comparing Charles River Laboratories International Inc and Illumina Inc

CRLCharles River Laboratories International Inc

ILMNIllumina Inc

CRLCharles River Laboratories International Inc

Market cap

$14.54B

P/E (TTM)

—

Forward P/E (NTM)

24.21x

Forward P/S (NTM)

3.68x

Rev growth (TTM)

-0.7%

YTD performance

49.1%

52W performance

74.0%

FCF yield

2.5%

ILMNIllumina Inc

Market cap

$42.09B

P/E (TTM)

51.59x

Forward P/E (NTM)

48.10x

Forward P/S (NTM)

8.72x

Rev growth (TTM)

4.9%

YTD performance

107.0%

52W performance

184.5%

FCF yield

2.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CRL

ILMN

Detailed metrics comparison

CRL

Charles River Laboratories International Inc

ILMN

Illumina Inc

Market Cap

CRL$14.54B

ILMN$42.09B

Enterprise Value

CRL$16.97B

ILMN$43.04B

Price

CRL$301.79

ILMN$278.17

P/E Ratio

CRLN/A

ILMN51.59x

P/S Ratio

CRL3.64x

ILMN9.37x

EV/Sales

CRL4.24x

ILMN9.58x

EV/EBITDA

CRL19.41x

ILMN36.11x

P/B Ratio

CRL4.88x

ILMN14.53x

P/FCF Ratio

CRL39.23x

ILMN45.21x

EV/FCF

CRL45.79x

ILMN46.23x

PEG Ratio

CRLN/A

ILMN4.18x

Forward P/E (NTM)

CRL24.21x

ILMN48.10x

Forward P/S (NTM)

CRL3.68x

ILMN8.72x

Revenue (TTM)

CRL$4.00B

ILMN$4.49B

Revenue Growth (YoY)

CRL-0.7%

ILMN4.9%

Forward Rev Growth

CRL2.3%

ILMN6.3%

Gross Margin (TTM)

CRL34.6%

ILMN66.4%

Operating Margin (TTM)

CRL2.3%

ILMN19.5%

EBITDA Margin (TTM)

CRL21.6%

ILMN26.2%

Net Margin (TTM)

CRL-6.0%

ILMN18.4%

FCF Margin (TTM)

CRL9.3%

ILMN20.7%

Net Income (TTM)

CRL$-238M

ILMN$825M

FCF (TTM)

CRL$371M

ILMN$931M

EPS (TTM)

CRL-$4.97

ILMN$5.39

ROE (TTM)

CRL-772.0%

ILMN31.1%

ROA (TTM)

CRL-319.0%

ILMN12.7%

ROIC (TTM)

CRL-434.0%

ILMN17.8%

Cash

CRL$192M

ILMN$1.04B

Debt

CRL$2.63B

ILMN$1.99B

Net Cash/Debt

CRL$-2.43B

ILMN$-951M

Current Ratio (TTM)

CRL1.35x

ILMN1.80x

Quick Ratio (TTM)

CRL0.83x

ILMN1.25x

Debt/Equity (TTM)

CRL0.93x

ILMN0.70x

Debt/Assets (TTM)

CRL0.0%

ILMN0.0%

Interest Coverage (TTM)

CRLN/A

ILMNN/A

Net Debt/EBITDA (TTM)

CRL0.00x

ILMN0.00x

Beta

CRL1.38

ILMN1.43

52W Performance

CRL74.0%

ILMN184.5%

YTD Performance

CRL49.1%

ILMN107.0%

% from 52W High

CRL-9.5%

ILMN-10.1%

% from 52W Low

CRL106.4%

ILMN216.1%

Asset Turnover (TTM)

CRL0.53x

ILMN0.69x

FCF Yield (TTM)

CRL2.5%

ILMN2.2%

Earnings Yield (TTM)

CRL-1.6%

ILMN2.0%

Dividend Yield (TTM)

CRLN/A

ILMNN/A

Rule of 40

CRL8.5

ILMN25.6

EV/GP/RG

CRL5.20

ILMN1.93

Ticker research

View CRL research View ILMN research

Metric	CRL Charles River Laboratories International Inc	ILMN Illumina Inc
Market & Valuation
Market Cap	$14.54B	$42.09B
Enterprise Value	$16.97B	$43.04B
Price	$301.79	$278.17
P/E Ratio	N/A	51.59x
P/S Ratio	3.64x	9.37x
EV/Sales	4.24x	9.58x
EV/EBITDA	19.41x	36.11x
P/B Ratio	4.88x	14.53x
P/FCF Ratio	39.23x	45.21x
EV/FCF	45.79x	46.23x
PEG Ratio	N/A	4.18x
Forward P/E (NTM)	24.21x	48.10x
Forward P/S (NTM)	3.68x	8.72x
Revenue & Growth
Revenue (TTM)	$4.00B	$4.49B
Revenue Growth (YoY)	-0.7%	4.9%
Forward Rev Growth	2.3%	6.3%
Profitability
Gross Margin (TTM)	34.6%	66.4%
Operating Margin (TTM)	2.3%	19.5%
EBITDA Margin (TTM)	21.6%	26.2%
Net Margin (TTM)	-6.0%	18.4%
FCF Margin (TTM)	9.3%	20.7%
Net Income (TTM)	$-238M	$825M
FCF (TTM)	$371M	$931M
EPS (TTM)	-$4.97	$5.39
ROE (TTM)	-772.0%	31.1%
ROA (TTM)	-319.0%	12.7%
ROIC (TTM)	-434.0%	17.8%
Financial Health
Cash	$192M	$1.04B
Debt	$2.63B	$1.99B
Net Cash/Debt	$-2.43B	$-951M
Current Ratio (TTM)	1.35x	1.80x
Quick Ratio (TTM)	0.83x	1.25x
Debt/Equity (TTM)	0.93x	0.70x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.38	1.43
52W Performance	74.0%	184.5%
YTD Performance	49.1%	107.0%
% from 52W High	-9.5%	-10.1%
% from 52W Low	106.4%	216.1%
Efficiency & Yields
Asset Turnover (TTM)	0.53x	0.69x
FCF Yield (TTM)	2.5%	2.2%
Earnings Yield (TTM)	-1.6%	2.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	8.5	25.6
EV/GP/RG	5.20	1.93
Ticker research	View CRL research	View ILMN research

Valuation

P/E Ratio

ILMN

51.59x

P/S Ratio

CRL

3.64x

ILMN

9.37x

EV/FCF

CRL

45.79x

ILMN

46.23x

Growth & revenue

Revenue Growth TTM

ILMN

4.9%

CRL

-0.7%

Forward Revenue Growth

ILMN

6.3%

CRL

2.3%

Profitability & performance

Gross Margin

ILMN

66.4%

CRL

34.6%

ROE

ILMN

31.1%

CRL

-772.0%

FCF Yield %

CRL

2.5%

ILMN

2.2%

52-Week Performance

ILMN

184.5%

CRL

74.0%

Detailed metrics comparison

CRL

Charles River Laboratories International Inc

ILMN

Illumina Inc

Market Cap

CRL$14.54B

ILMN$42.09B

Enterprise Value

CRL$16.97B

ILMN$43.04B

Price

CRL$301.79

ILMN$278.17

P/E Ratio

CRLN/A

ILMN51.59x

P/S Ratio

CRL3.64x

ILMN9.37x

EV/Sales

CRL4.24x

ILMN9.58x

EV/EBITDA

CRL19.41x

ILMN36.11x

P/B Ratio

CRL4.88x

ILMN14.53x

P/FCF Ratio

CRL39.23x

ILMN45.21x

EV/FCF

CRL45.79x

ILMN46.23x

PEG Ratio

CRLN/A

ILMN4.18x

Forward P/E (NTM)

CRL24.21x

ILMN48.10x

Forward P/S (NTM)

CRL3.68x

ILMN8.72x

Revenue (TTM)

CRL$4.00B

ILMN$4.49B

Revenue Growth (YoY)

CRL-0.7%

ILMN4.9%

Forward Rev Growth

CRL2.3%

ILMN6.3%

Gross Margin (TTM)

CRL34.6%

ILMN66.4%

Operating Margin (TTM)

CRL2.3%

ILMN19.5%

EBITDA Margin (TTM)

CRL21.6%

ILMN26.2%

Net Margin (TTM)

CRL-6.0%

ILMN18.4%

FCF Margin (TTM)

CRL9.3%

ILMN20.7%

Net Income (TTM)

CRL$-238M

ILMN$825M

FCF (TTM)

CRL$371M

ILMN$931M

EPS (TTM)

CRL-$4.97

ILMN$5.39

ROE (TTM)

CRL-772.0%

ILMN31.1%

ROA (TTM)

CRL-319.0%

ILMN12.7%

ROIC (TTM)

CRL-434.0%

ILMN17.8%

Cash

CRL$192M

ILMN$1.04B

Debt

CRL$2.63B

ILMN$1.99B

Net Cash/Debt

CRL$-2.43B

ILMN$-951M

Current Ratio (TTM)

CRL1.35x

ILMN1.80x

Quick Ratio (TTM)

CRL0.83x

ILMN1.25x

Debt/Equity (TTM)

CRL0.93x

ILMN0.70x

Debt/Assets (TTM)

CRL0.0%

ILMN0.0%

Interest Coverage (TTM)

CRLN/A

ILMNN/A

Net Debt/EBITDA (TTM)

CRL0.00x

ILMN0.00x

Beta

CRL1.38

ILMN1.43

52W Performance

CRL74.0%

ILMN184.5%

YTD Performance

CRL49.1%

ILMN107.0%

% from 52W High

CRL-9.5%

ILMN-10.1%

% from 52W Low

CRL106.4%

ILMN216.1%

Asset Turnover (TTM)

CRL0.53x

ILMN0.69x

FCF Yield (TTM)

CRL2.5%

ILMN2.2%

Earnings Yield (TTM)

CRL-1.6%

ILMN2.0%

Dividend Yield (TTM)

CRLN/A

ILMNN/A

Rule of 40

CRL8.5

ILMN25.6

EV/GP/RG

CRL5.20

ILMN1.93

Ticker research

View CRL research View ILMN research

Metric	CRL Charles River Laboratories International Inc	ILMN Illumina Inc
Market & Valuation
Market Cap	$14.54B	$42.09B
Enterprise Value	$16.97B	$43.04B
Price	$301.79	$278.17
P/E Ratio	N/A	51.59x
P/S Ratio	3.64x	9.37x
EV/Sales	4.24x	9.58x
EV/EBITDA	19.41x	36.11x
P/B Ratio	4.88x	14.53x
P/FCF Ratio	39.23x	45.21x
EV/FCF	45.79x	46.23x
PEG Ratio	N/A	4.18x
Forward P/E (NTM)	24.21x	48.10x
Forward P/S (NTM)	3.68x	8.72x
Revenue & Growth
Revenue (TTM)	$4.00B	$4.49B
Revenue Growth (YoY)	-0.7%	4.9%
Forward Rev Growth	2.3%	6.3%
Profitability
Gross Margin (TTM)	34.6%	66.4%
Operating Margin (TTM)	2.3%	19.5%
EBITDA Margin (TTM)	21.6%	26.2%
Net Margin (TTM)	-6.0%	18.4%
FCF Margin (TTM)	9.3%	20.7%
Net Income (TTM)	$-238M	$825M
FCF (TTM)	$371M	$931M
EPS (TTM)	-$4.97	$5.39
ROE (TTM)	-772.0%	31.1%
ROA (TTM)	-319.0%	12.7%
ROIC (TTM)	-434.0%	17.8%
Financial Health
Cash	$192M	$1.04B
Debt	$2.63B	$1.99B
Net Cash/Debt	$-2.43B	$-951M
Current Ratio (TTM)	1.35x	1.80x
Quick Ratio (TTM)	0.83x	1.25x
Debt/Equity (TTM)	0.93x	0.70x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.38	1.43
52W Performance	74.0%	184.5%
YTD Performance	49.1%	107.0%
% from 52W High	-9.5%	-10.1%
% from 52W Low	106.4%	216.1%
Efficiency & Yields
Asset Turnover (TTM)	0.53x	0.69x
FCF Yield (TTM)	2.5%	2.2%
Earnings Yield (TTM)	-1.6%	2.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	8.5	25.6
EV/GP/RG	5.20	1.93
Ticker research	View CRL research	View ILMN research